Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Stoke Therapeutics is seeking a Sr. Clinical Trial Manager to serve as a Global Study Lead, providing oversight to CROs and vendors from protocol concept through study report. The role focuses on study startup, execution, risk management, and cross-functional coordination to ensure quality deliverables.
Location is in Bedford/Waltham, MA with a remote/hybrid work model and approximately 15% travel. Pediatric rare disease and neurology experience are highly desirable, with flexibility to adapt to
Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine. Using Stoke’s proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to selectively restore naturally-occurring protein levels. Stoke’s first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome and is currently being evaluated in a Phase 3 study. Stoke’s initial focus are diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and systems, supporting broad potential for Stoke’s proprietary approach. Stoke is headquartered in Bedford, Massachusetts. For more information, visit https://www.stoketherapeutics.com/
Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine. Using Stoke’s proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to selectively restore naturally-occurring protein levels. Stoke’s first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome and is currently being evaluated in a Phase 3 study. Stoke’s initial focus are diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and systems, supporting broad potential for Stoke’s proprietary approach. Stoke is headquartered in Bedford, Massachusetts. For more information, visit https://www.stoketherapeutics.com/
The Sr. Clinical Trial Manager must have experience as a Global Study Lead in an outsourced model (i.e. providing oversight to CROs and vendors), as well as managing vendors, with a focus on study start up and study execution to ensure vendor/system/and cross functional integration throughout the study. The Sr. CTM is responsible for the successful execution of a clinical trial from protocol concept through clinical study report, ensuring completion of all study deliverables, including proactive risk/issue identification and mitigations. Ideally, the candidate has rare disease and pediatric experience (preferable, not required), as well as dose escalating/dose finding study experience that includes Safety Monitoring Committee (SMC).
Stoke is located in Bedford, MA, and will be moving to a new location in Waltham, MA by the end of 2026. This position is remote, with on site work approximately 1 day a week, and the flexibility to be in the office when needed, currently based in Bedford and will later be based in Waltham.
This position will require approximately 15% travel.
At Stoke, we believe that innovation, the ability to successfully advance our ground-breaking science and having fun as a team are enhanced by being together in person, at least periodically. We allow for flexibility in work arrangements that balance individual’s needs and preferences with the needs of our business and our desire to foster a culture of collaboration and innovation.
Our values guide our work to deliver meaningful medicines for people who need them. We are committed to being true to ourselves, to our colleagues, and to the people with severe diseases who are counting on us. We embrace diversity within a unique culture that is defined by our values. Our employee-led Diversity, Inclusion, and Belonging (DIB) Committee underscores the importance of DIB to who we are and what we do.
https://www.stoketherapeutics.com/careers/
For more information, visit https://www.stoketherapeutics.com/.
All applicants will receive consideration for employment without regard to race, color, age, religion, sex, sexual orientation, gender identity, national origin, physical or mental disability or protected veteran status.
Stoke participates in E-Verify.